Results 161 to 170 of about 61,653 (192)

Design, synthesis, and anti-urease evaluations of new sulfonamide-1,2,3-triazole-acetamide derivatives. [PDF]

Sci Rep
Varzaneh SB, Shokouhi Asl AS, Sayahi MH, Taherkhani AM, Talebi M, Dastyafteh N, Safapoor S, Emadi M, Alikhani M, Yazzaf R, Halimi M, Amanlou M, Larijani B, Mohammadi-Khanaposhtani M, Mahdavi M.   +14 more
europepmc   +1 more source

Hybrid 2-Quinolone-1,2,3-triazole Compounds: Rational Design, In Silico Optimization, Synthesis, Characterization, and Antibacterial Evaluation. [PDF]

Antibiotics (Basel)
El-Mrabet A, Diane A, Haloui R, El Monfalouti H, S Alanazi A, Hefnawy M, Alanazi MM, Alanazi MM, Kandri-Rodi Y, Elkhattabi S, Mazzah A, Haoudi A, Kheira Sebbar N.   +12 more
europepmc   +1 more source

Construction of 1,2,3-Triazole-Embedded Polyheterocyclic Compounds via CuAAC and C-H Activation Strategies. [PDF]

Molecules
Iazzetti A, Allevi D, Fabrizi G, Gazzilli Y, Goggiamani A, Marrone F, Stipa F, Ullah K, Zoppoli R.   +8 more
europepmc   +1 more source

Novel compounds with promising HuH-7 inhibitory activity as new cancer drug candidates: derivatives of N,N'-diphenylurea linked with 1,2,3-triazole. [PDF]

J Enzyme Inhib Med Chem
Guo Y, Long H, Zhang H, Wang D, Wu H, Chen X, Mao L, Gao E, Wang T.   +8 more
europepmc   +1 more source

From chemistry to targeted cancer therapy: potent benzimidazole-1,2,3-triazole hybrid-loaded nanogels against breast and colorectal malignancies. [PDF]

RSC Adv
Malebari AM, Ali MAM, Musa A, Zaki MEA, Gomha SM, Soliman MA, Abdelgawad MA, Thomas Parambi DG, Aouad MR, Abulkhair HS, Ahmed HEA.   +10 more
europepmc   +1 more source

New 5,6-diphenyl-1,2,4-triazine-hydrazineylidene-phenoxy-1,2,3-triazole-acetamide derivatives as potent synthetic α-glucosidase inhibitors. [PDF]

RSC Adv
Asemanipoor N, Moradi S, Faramarzi MA, Mohammadi-Khanaposhtani M, Mahdavi M.   +4 more
europepmc   +1 more source

Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-<i>N</i>-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors. [PDF]

RSC Adv
Bakhshi Varzaneh S, Sayahi MH, Halimi M, Ghafouri SN, Dastyafteh N, Mojtabavi S, Larijani B, Mohammadi-Khanaposhtani M, Mahdavi M.   +8 more
europepmc   +1 more source

Enzymatic, cell-based, and <i>in silico</i> evaluation of di-substituted aminomethyl-1,2,3-triazole-cinamamide hybrids as mushroom tyrosinase inhibitors. [PDF]

RSC Adv
Dastyafteh N, Sayahi MH, Morshedsolouk MH, Safapoor S, Mahdavi M, Saeedi M, Hamedifar H, Sepehri N, Iraji A.   +8 more
europepmc   +1 more source

Synthesis and evaluation of quinolinvinyl-phenoxy-1,2,3-triazole-acetamide hybrids against breast cancer. [PDF]

Sci Rep
Safavi M, Iraji A, Farid SM, Mahdavi M, Fattaheian-Dehkordi S, Akbarzadeh T, Saeedi M.   +6 more
europepmc   +1 more source